Professor, Medicine, Tulane University School of Medicine
Cardiology
Dr. Keith C. Ferdinand, MD
|
|
Give Review
Doctor Keith C. Ferdinand, MD is an expert in the field of Cardiology. He studied medicine at Howard University College of Medicine. He over the years received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Keith Ferdinand is a published physician. He has 79 publications published. The most current publication "Emergence of Nonobstructive CoronaryArtery Disease: A Woman's Problem and Need for Change in DefinitiononAngiography." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.
- Recognition and Management of Hypertension in Older Persons: Focus on African Americans.
- Understanding the importance of race/ethnicity in the care of the hypertensive patient.
- Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks.
- Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus.
- Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals.
- A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with Hypertension.
- Obesity and Hypertension: It's about more than the numbers.
- Hypertension in the US Black Population: Risk Factors, Complications, and Potential Impact of Central Aortic Pressure on Effective Treatment.
- Progression is accelerated from preHypertension to Hypertension in blacks.
- A compendium of antihypertensive therapy.
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008.
- Combination Angiotensin-Receptor Blocker (ARB)/Calcium Channel Blocker With HCTZ vs the Maximal Recommended Dose of an ARB With HCTZ in Patients With Stage???2 Hyperte...
- The Impact of Lipoic Acid on Endothelial Function and Proteinuria in Quinapril-Treated Diabetic Patients With Stage I Hypertension: Results From the QUALITY Study.
- Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuv...
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensu...
- Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hyper...
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consens...
- Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 Hypertension.
- Treatment of Heart failure in African Americans--a call to action.
- Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?
- ASH Hypertension Community Outreach Program: taking action to address a "neglected Disease".
- Management of high blood pressure in African Americans and the 2010 ISHIB consensus statement: meeting an unmet need.
- Achieving treatment goals in low-risk, asymptomatic patients.
- News from recent clinical trials: Implications for clinical practice and the treatment of Hypertension.
- Treatment of Heart failure in African Americans: executive summary.
- Trends in Hypertension treatment in diabetes.
- Nebivolol in high-risk, obese African Americans with stage 1 Hypertension: effects on blood pressure, vascular compliance, and endothelial function.
- Patients with Hypertension and the cardiometabolic syndrome: the potential impact of inflammatory biomarkers.
- Underutilization of angiotensin-converting enzyme inhibitors in high-risk blacks: a case of missed opportunities.
- Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.
- Realities of newer beta-blockers for the management of Hypertension.
- Eliminating disparities in hypertension, metabolic syndrome, kidney Failure, and cardiovascular disease: basic science, clinical practice and community initiatives. Fo...
- Relationship of ethnic origin, gender, and age to blood creatine kinase levels.
- The management of Hypertension with angiotensin receptor blockers in special populations.
- Cardiovascular Disease in blacks: can we stop the clock?
- Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.
- Blood pressure control in the patient with difficult-to-control Hypertension: which agent for which patient?
- Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
- Noninvasive diagnosis of subclinical atherosclerosis in cardiometabolic syndrome: a call to action.
- Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with Hypertension uncontrolled with monotherapy.
- Cardiovascular health in patients with serious mental illnesses: we need to do more.
- The management of Hypertension in the African American patient.
- Cardiovascular Disease and African Americans: why determination of race is inadequate for research and practice.
- The management of Hypertension in African Americans.
- Barbershops as Hypertension detection, referral, and follow-up centers for black men.
- African American Heart failure trial: role of endothelial dysfunction and Heart failure in African Americans.
- New antihypertensive agents: will they work in blacks?
- New evidence confirms risks associated with preHypertension and benefits of therapeutic lifestyle changes in management.
- The cardiometabolic syndrome and cardiovascular Disease in racial and ethnic minorities: new areas of research and intervention.
- Management of Hypertension and dyslipidemia.
- Ethnic, gender, and age-related differences in the treatment of dyslipidemia.
- Hypertension in minority populations.
- Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.
- The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
- Public health and Hurricane Katrina: lessons learned and what we can do now.
- Coronary artery disease in minority racial and ethnic groups in the United States.
- Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
- Hypertension-related morbidity and mortality in African Americans--why we need to do better.
- Hypertension and the cardiometabolic syndrome--is it the blood pressure lowering or the blood pressure medication that is important?
- PreHypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
- The Hurricane Katrina disaster: focus on the hypertensive patient.
- A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
- Managing cardiovascular risk in minority patients.
- Retrospective analysis: consensus statement of the Hypertension in African Americans working group of the International Society on Hypertension in Blacks (ISHIB).
- The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials.
- Coronary Heart disease and lipid-modifying treatment in African American patients.
- The epidemic of diabetes mellitus and the metabolic syndrome in African Americans.
- Recommendations for the management of special populations: racial and ethnic populations.
- Introduction: management of Hypertension and cardiovascular risk factors in African Americans.
- For the patient. What is the Metabolic Syndrome and why is it important?
- From protocol to practice: translating the clinical data into clinical practice.
- Hypertension-related Disease in African Americans. Factors underlying disparities in illness and its outcome.
- Optimal treatment of Hypertension in African Americans. Reaching and maintaining target blood pressure goals.
- Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained.
- Contemporary treatment of Heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.
- Roundtable discussion: hypertension, renal Disease, and diabetes.
- Substance Abuse and Hypertension.
Schools
Howard University College Of Medicine
USPHS Hospital
Charity Hospital La State University
Howard University HospItal
Procedures Preformed
- Cardiac Imaging
Conditions Treated
- Congestive Heart Failure
- Coronary Artery Disease (CAD)
- Hypertension
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice HMO
- Blue Choice Option POS
- Blue Open Access POS
- Direct Access w/HSA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Howard University College of Medicine
Drug Facts
| NPI NUMBER | 1851398622 | |
| NPPES Provider LastName | FERDINAND | |
| NPPES Provider FirstName | KEITH | |
| NPPES Provider ZIPCode | 701305022 | |
| NPPES Provider State | LA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 43.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851398622 |
| Last Name Of The Provider | FERDINAND |
| First Name Of The Provider | KEITH |
| View All |
Similar Doctors
|
|
Dr. Sylvia A. Oleck, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Olle Kjellgren, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hector O. Ventura, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul W. McMullan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Glancy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Cassidy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Patrick A. Delaney Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vishal A. Vyas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Monique P. Brimmer-Williams, NPC |
|
|
Dr. Paul A. Rogers, MD |
|
|
Linda M. Joseph, CNS
This Doctor is OpenDoctor Recommended.
|